Table 2.
Characteristics of the enrolled participants at baseline
| Variable | HCC group (n=160) |
CHB group (n=88) |
HC group (n=45) |
|---|---|---|---|
| Age (yr) | 55.00(46.25-61.00) | 46.50(39.25-58.00) | 42.00(37.5-54.50) |
| Male gender (%) | 132(82.5%) | 61(69.32%) | 28(62.22%) |
| HBeAg+, N(%) | 35(21.88%) | 46(52.27%) | NA |
| ALT (U/L) | 34.00(21.25-66.00) | 87.5 (35.00-155.00) | NA |
| AST (U/L) | 40.50(25.25-81.00) | 66.00(44.50-116.50) | NA |
| TBIL (μmol/L) | 15.70 (11.85-22.70) | 22.75 (14.53-49.58) | NA |
| ALB (g/L) | 40.00(35.00-42.88) | 34.00(28.68-41.70) | NA |
| PT-INR | 1.03(0.97-1.09) | 1.14(1.00-1.34) | NA |
| AFP (ng/mL) | 60.22(4.36-276.70) | 22.05(4.13-50.64) | NA |
| Methylation, N(%) | 77(48.13%) | 12(13.64%) | 2(4.44%) |
NA, not available